• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内胆管癌中Hippo信号通路分子的表达改变

Altered Expression of Hippo Signaling Pathway Molecules in Intrahepatic Cholangiocarcinoma.

作者信息

Sugimachi Keishi, Nishio Miki, Aishima Shinichi, Kuroda Yosuke, Iguchi Tomohiro, Komatsu Hisateru, Hirata Hidenari, Sakimura Shotaro, Eguchi Hidetoshi, Bekki Yuki, Takenaka Kenji, Maehara Yoshihiko, Suzuki Akira, Mimori Koshi

机构信息

Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan.

出版信息

Oncology. 2017;93(1):67-74. doi: 10.1159/000463390. Epub 2017 Apr 28.

DOI:10.1159/000463390
PMID:28448997
Abstract

OBJECTIVE

MOB1, a core component of the Hippo signaling pathway, suppresses cell proliferation, and MOB1 liver conditional knockout mice develop intrahepatic cholangiocarcinoma (ICC). However, its clinical significance in human ICC has not been established. The aim of this study was to characterize protein levels and the role of Hippo and TGF pathways in ICCs.

METHODS

The protein levels of yes-associated protein 1 (YAP1), MOB1, Smad2, and TGFβ2 in 88 ICC cases were analyzed. Protein level was graded by a scoring system; then, the clinicopathological factors, including prognosis, were analyzed based on protein level.

RESULTS

Nuclear overexpression of YAP1 was seen in 28 cases (31.8%), and it was significantly associated with a poor overall survival rate (p = 0.01). MOB1 expression decreased in 42 cases (47.7%) and was associated with a poor overall survival rate (p = 0.02). SMAD2 nuclear localization was significantly correlated with a high YAP1 level independent of TGFβ2. Multivariate analysis revealed that a high YAP1 level, a low MOB1 level, and lymphatic permeation were independent risk factors for overall survival.

CONCLUSIONS

These results showed that key components of the Hippo signaling pathway are aberrantly expressed and associated with the malignant potential of human ICC.

摘要

目的

MOB1是Hippo信号通路的核心组成部分,可抑制细胞增殖,MOB1肝脏条件性敲除小鼠会发生肝内胆管癌(ICC)。然而,其在人类ICC中的临床意义尚未明确。本研究旨在明确Hippo和TGF通路在ICC中的蛋白水平及作用。

方法

分析88例ICC病例中Yes相关蛋白1(YAP1)、MOB1、Smad2和TGFβ2的蛋白水平。通过评分系统对蛋白水平进行分级;然后,根据蛋白水平分析包括预后在内的临床病理因素。

结果

28例(31.8%)出现YAP1核过表达,且与总体生存率低显著相关(p = 0.01)。42例(47.7%)MOB1表达降低,且与总体生存率低相关(p = 0.02)。SMAD2核定位与高YAP1水平显著相关,且独立于TGFβ2。多因素分析显示,高YAP1水平、低MOB1水平和淋巴浸润是总体生存的独立危险因素。

结论

这些结果表明,Hippo信号通路的关键成分表达异常,并与人类ICC的恶性潜能相关。

相似文献

1
Altered Expression of Hippo Signaling Pathway Molecules in Intrahepatic Cholangiocarcinoma.肝内胆管癌中Hippo信号通路分子的表达改变
Oncology. 2017;93(1):67-74. doi: 10.1159/000463390. Epub 2017 Apr 28.
2
Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.YAP1/TAZ信号通路失调和TGF-β信号传导介导Mob1a/1b基因缺陷小鼠的肝癌发生。
Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):E71-80. doi: 10.1073/pnas.1517188113. Epub 2015 Dec 22.
3
Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.14-3-3ζ在肝内胆管癌中的表达上调及其临床意义
Tumour Biol. 2015 Mar;36(3):1781-9. doi: 10.1007/s13277-014-2780-5. Epub 2014 Nov 13.
4
Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.自分泌甲状旁腺素样激素通过增加 ERK/JNK-ATF2-cyclinD1 信号通路促进肝内胆管癌细胞增殖。
J Transl Med. 2017 Nov 25;15(1):238. doi: 10.1186/s12967-017-1342-1.
5
Loss of FoxA2 accelerates neoplastic changes in the intrahepatic bile duct partly via the MAPK signaling pathway.FoxA2的缺失部分通过丝裂原活化蛋白激酶(MAPK)信号通路加速肝内胆管的肿瘤性变化。
Aging (Albany NY). 2019 Nov 5;11(21):9280-9294. doi: 10.18632/aging.102332.
6
EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.EYA4基因作为一种预后标志物发挥作用,并抑制肝内胆管癌的生长。
Chin J Cancer. 2016 Jul 28;35(1):70. doi: 10.1186/s40880-016-0133-z.
7
Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.程序性死亡配体 1 的表达与肝内胆管癌的预后相关。
Dig Dis Sci. 2020 Feb;65(2):480-488. doi: 10.1007/s10620-019-05787-0. Epub 2019 Aug 13.
8
The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma.细胞周期蛋白D1过表达和基因扩增在肝内胆管癌中的作用。
J Hepatol. 2001 Jul;35(1):74-9. doi: 10.1016/s0168-8278(01)00079-4.
9
Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy.靶向 Hippo/YAP 在肝内胆管癌中的作用:癌症治疗中的有前途的分子。
Mol Carcinog. 2024 Oct;63(10):1866-1873. doi: 10.1002/mc.23791. Epub 2024 Aug 2.
10
Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis.Tropomyosin 1 在肝内胆管癌中的低表达:复发和预后的预测因子。
Med Sci Monit. 2018 Nov 3;24:7875-7882. doi: 10.12659/MSM.907340.

引用本文的文献

1
RHBDF1 modulates cisplatin sensitivity of small cell lung cancer through YAP1/Smad2 signaling pathway.RHBDF1通过YAP1/Smad2信号通路调节小细胞肺癌对顺铂的敏感性。
Heliyon. 2024 Jun 22;10(13):e33454. doi: 10.1016/j.heliyon.2024.e33454. eCollection 2024 Jul 15.
2
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression.YAP/TAZ 与代谢相关脂肪性肝病进展的相互作用。
Arch Pharm Res. 2024 Jun;47(6):558-570. doi: 10.1007/s12272-024-01501-5. Epub 2024 Jun 14.
3
MOB kinase activator 1A acts as an oncogene by targeting PI3K/AKT/mTOR in ovarian cancer.
MOB激酶激活剂1A通过靶向卵巢癌中的PI3K/AKT/mTOR发挥癌基因作用。
Discov Oncol. 2023 Jun 14;14(1):100. doi: 10.1007/s12672-023-00705-3.
4
Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway.肝细胞癌和肝内胆管癌的预后及治疗靶点研究进展:河马信号通路
Front Oncol. 2022 Aug 12;12:937957. doi: 10.3389/fonc.2022.937957. eCollection 2022.
5
YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of intrahepatic cholangiocarcinoma.YAP1 激活与 Hippo 通路信号在肝内胆管癌发病机制及治疗中的作用。
Adv Cancer Res. 2022;156:283-317. doi: 10.1016/bs.acr.2022.02.003. Epub 2022 Mar 9.
6
Relationship between Yes-Associated Protein 1 and Prognosis of Digestive System Neoplasm: Quantitative Analysis and Bioinformatics Analysis Based on 4023 Patients.Yes相关蛋白1与消化系统肿瘤预后的关系:基于4023例患者的定量分析和生物信息学分析
Evid Based Complement Alternat Med. 2022 Jul 19;2022:3798694. doi: 10.1155/2022/3798694. eCollection 2022.
7
R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway.R-2HG通过FTO/m6A甲基化的雌激素受体α(ERα)/miR16-5p/YAP1信号通路下调ERα以抑制胆管癌。
Mol Ther Oncolytics. 2021 Jul 10;23:65-81. doi: 10.1016/j.omto.2021.06.017. eCollection 2021 Dec 17.
8
Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma.YAP 和 TAZ 的共表达与人类胆管癌中的染色体不稳定性相关。
BMC Cancer. 2021 Oct 6;21(1):1079. doi: 10.1186/s12885-021-08794-5.
9
YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice.YAP 通过 mTORC1 促进小鼠 Notch 驱动的胆管癌发生。
Am J Pathol. 2021 Sep;191(9):1651-1667. doi: 10.1016/j.ajpath.2021.05.017. Epub 2021 Jun 12.
10
YAP Activation and Implications in Patients and a Mouse Model of Biliary Atresia.YAP激活及其在胆道闭锁患者和小鼠模型中的意义
Front Pediatr. 2021 Jan 21;8:618226. doi: 10.3389/fped.2020.618226. eCollection 2020.